Top

Reactions Weekly

Published in:

01-11-2023 | Canagliflozin | Case report

Canagliflozin/metformin/sitagliptin

Lack of efficacy and euglycaemic diabetic ketoacidosis

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Manas F, et al. Euglycemic Diabetic Ketoacidosis With SGLT-2 Inhibitor. Journal of the Endocrine Society 5 (Suppl. 1): A381-A382, May 2021. Available from: URL: https://dx.doi.org/10.1210/jendso/bvab048.777 [abstract]

Title: Canagliflozin/metformin/sitagliptin
Lack of efficacy and euglycaemic diabetic ketoacidosis
Publication date: 01-11-2023
Publisher: Springer International Publishing
Keywords: Canagliflozin
Sitagliptin
Ketoacidosis
Metformin
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-50369-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Canagliflozin/metformin/sitagliptin

Lack of efficacy and euglycaemic diabetic ketoacidosis

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Olanzapine

Multiple drugs

Antineoplastics

Antineoplastics

Multiple drugs

Fidaxomicin/metronidazole/vancomycin